Terms: = Pancreatic cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Staging
4 results:
1. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
[TBL] [Abstract] [Full Text] [Related]
2. Long-term cancer Survival Trends by Updated Summary Stage.
Forjaz G; Ries L; Devasia TP; Flynn G; Ruhl J; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1508-1517. PubMed ID: 37623930
[TBL] [Abstract] [Full Text] [Related]
3. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract] [Full Text] [Related]
4. A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma.
Sakaguchi T; Satoi S; Hashimoto D; Yamamoto T; Yamaki S; Hirooka S; Ishida M; Ikeura T; Inoue K; Sekimoto M
J Hepatobiliary Pancreat Sci; 2022 Feb; 29(2):262-270. PubMed ID: 34314568
[TBL] [Abstract] [Full Text] [Related]
